Publications

Publications

An up-to-date list of our publications is available on Google Scholar.

2026

  1. Integrative structure of norovirus NS3 suggests a role in RNA transport

    Haas, M., Hoeksma, T., Mills, J. T., Kelley, C., Das, A., Shyam, K. T., Veenstra, R., Byford, O., Hóf, H., Niemel, C., Donselaar, T., Drulyte, I., van Kuppeveld, F. J. M., Dulin, D., Snijder, J., Herod, M. R., & Hurdiss, D. L.

    Nature Communications, 17(1), Article 10991.

  2. Structure-based macrocyclization of α-ketoamides leads to potent inhibitors of coronaviral and enteroviral proteases

    Akula, R. K., El Kilani, H., Metzen, A., Joshi, S., Durmaz, H., Veenstra, R., Röske, J., Hurdiss, D. L., Van Kuppeveld, F. J. M., Rox, K., Hilgenfeld, R., & Brönstrup, M.

    Communications Chemistry, 9(1), Article 269.

  3. Spike and host glycan determinants of HKU1 airway tropism Preprint

    Creutznacher, R., Wallace, L., Debski Antoniak, O., Drulyte, I., Hulswit, R., Beekman, J. M., van Kuppeveld, F., Bosch, B. J., de Haan, X., Frank, M., Hurdiss, D., & de Groot, R.

    bioRxiv.

  4. Structure of SARS-CoV-2 spike in complex with its co-receptor the neuronal cell adhesion protein contactin 1 Preprint

    Krepel, S. T., Hurdiss, D. L., Bosch, B. J., Snijder, J., & Janssen, B. J. C.

    bioRxiv.

  5. Cetacean coronavirus spikes highlight S glycoprotein structural plasticity

    Hulswit, R. J. G., Shamorkina, T. M., van der Lee, J., Rosman, F., Wetzels, L. S., van Kuppeveld, F. J. M., Snijder, J., Bosch, B. J., & Hurdiss, D. L.

    PLoS Pathogens, 22(4 April), Article e1013855.

  6. AI-guided prefusion stabilization of the human coronavirus OC43 spike protein enables universal embecovirus antigen design

    Melchers, J. M., Juraszek, J., Hulswit, R. J. G., van Overveld, D., Le, L., van Kuppeveld, F. J. M., Hurdiss, D. L., Bosch, B.-J., Langedijk, J. P. M., & Bakkers, M. J. G.

    PLoS Pathogens, 22(3 March), Article e1013998.

2025

  1. Integrative Structure of Norovirus NS3 Suggests a Role in RNA Transport Preprint

    Haas, M., Mills, J. T., Kelley, C., Das, A., Hóf, H., Niemel, C., Donselaar, T., Drulyte, I., van Kuppeveld, F. J. M., Dulin, D., Snijder, J., Herod, M. R., & Hurdiss, D. L.

    bioRxiv.

  2. Cetacean coronavirus spikes highlight S glycoprotein structural plasticity Preprint

    Hulswit, R. J. G., Shamorkina, T. M., van der Lee, J., Rosman, F., Wetzels, L. S., van Kuppeveld, F. J. M., Snijder, J., Bosch, B. J., & Hurdiss, D. L.

    bioRxiv.

  3. Cryo-Electron Microscopy-Based Epitope Mapping

    Drulyte, I., & Hurdiss, D. L.

    Methods in molecular biology (Clifton, N.J.), 2937, 61-77.

  4. Computational design of therapeutic antibodies with improved developability: efficient traversal of binder landscapes and rescue of escape mutations

    Dreyer, F. A., Schneider, C., Kovaltsuk, A., Cutting, D., Byrne, M. J., Nissley, D. A., Kenlay, H., Marks, C., Errington, D., Gildea, R. J., Damerell, D., Tizei, P., Bunjobpol, W., Darby, J. F., Drulyte, I., Hurdiss, D. L., Surade, S., Wahome, N., Pires, D. E. V., & Deane, C. M.

    mAbs, 17(1), 1-18. Article 2511220.

  5. A coronavirus assembly inhibitor that targets the viral membrane protein

    Laporte, M., Jochmans, D., Bardiot, D., Desmarets, L., Debski-Antoniak, O. J., Mizzon, G., Abdelnabi, R., Leyssen, P., Chiu, W., Zhang, Z., Nomura, N., Boland, S., Ohto, U., Stahl, Y., Wuyts, J., De Jonghe, S., Stevaert, A., van Hemert, M. J., Bontes, B. W., ... Neyts, J.

    Nature, 640(8058), 514–523. Article 4399.

  6. A bivalent spike-targeting nanobody with anti-sarbecovirus activity

    Swart, I. C., Debski-Antoniak, O. J., Zegar, A., de Bouter, T., Chatziandreou, M., van den Berg, M., Drulyte, I., Pyrc, K., de Haan, C. A. M., Hurdiss, D. L., Bosch, B.-J., & Oliveira, S.

    Journal of Nanobiotechnology, 23(1), Article 196.

2024

  1. A Spike Trimer Dimer-Inducing Nanobody with Anti-Sarbecovirus Activity Preprint

    Swart, I. C., Debski-Antoniak, O. J., Zegar, A., de Bouter, T., Chatziandreou, M., van den Berg, M., Drulyte, I., Pyrć, K., de Haan, C. A. M., Hurdiss, D. L., Bosch, B.-J., & Oliveira, S.

    bioRxiv.

  2. Neutralizing antibodies reveal cryptic vulnerabilities and interdomain crosstalk in the porcine deltacoronavirus spike protein

    Du, W., Debski-Antoniak, O., Drabek, D., van Haperen, R., van Dortmondt, M., van der Lee, J., Drulyte, I., van Kuppeveld, F. J. M., Grosveld, F., Hurdiss, D. L., & Bosch, B.-J.

    Nature Communications, 15(1), Article 5330.

  3. Nanoparticle display of neuraminidase elicits enhanced antibody responses and protection against influenza A virus challenge

    Pascha, M. N., Ballegeer, M., Roelofs, M. C., Meuris, L., Albulescu, I. C., van Kuppeveld, F. J. M., Hurdiss, D. L., Bosch, B. J., Zeev-Ben-Mordehai, T., Saelens, X., & de Haan, C. A. M.

    npj Vaccines, 9(1), Article 97.

  4. Nanoparticle display of neuraminidase elicits enhanced antibody responses and protection against influenza A virus challenge in mice

    Pascha, M. N., Ballegeer, M., Roelofs, M. C., Meuris, L., Albulescu, I. C., Kuppeveld, F. J. M. V., Hurdiss, D. L., Bosch, B.-J., Zeev-Ben-Mordehai, T., Saelens, X., & Haan, C. A. M. D.

    Research Square.

2023

  1. SARS-CoV-2 nucleocapsid protein inhibits the stress response through RNA-binding domain N2b Preprint

    Aloise, C., Schipper, J. G., Donselaar, T., Hurdiss, D. L., de Groot, R. J., & van Kuppeveld, F. J. M.

    bioRxiv.

  2. Sialoglycan binding triggers spike opening in a human coronavirus

    Pronker, M. F., Creutznacher, R., Drulyte, I., Hulswit, R. J. G., Li, Z., van Kuppeveld, F. J. M., Snijder, J., Lang, Y., Bosch, B.-J., Boons, G.-J., Frank, M., de Groot, R. J., & Hurdiss, D. L.

    Nature, 624(7990), 201-206.

  3. A broad-spectrum macrocyclic peptide inhibitor of the SARS-CoV-2 spike protein Preprint

    Thijssen, V., Hurdiss, D. L., Debski-Antoniak, O. J., Spence, M. A., Franck, C., Norman, A., Aggarwal, A., Mokiem, N. J., Dongen, D. A. A. V., Vermeir, S. W., Liu, M., Li, W., Chatziandreou, M., Donselaar, T., Du, W., Drulyte, I., Bosch, B.-J., Snijder, J., Turville, S., ... Jongkees, S. A. K.

    (pp. 1-27). bioRxiv.

  4. SARS-CoV-2 nucleocapsid protein inhibits the PKR-mediated integrated stress response through RNA-binding domain N2b

    Aloise, C., Schipper, J. G., van Vliet, A., Oymans, J., Donselaar, T., Hurdiss, D. L., de Groot, R. J., & van Kuppeveld, F. J. M.

    PLoS Pathogens, 19(8), Article e1011582.

  5. A broad-spectrum macrocyclic peptide inhibitor of the SARS-CoV-2 spike protein

    Thijssen, V., Hurdiss, D. L., Debski-Antoniak, O. J., Spence, M. A., Franck, C., Norman, A., Aggarwal, A., Mokiem, N. J., van Dongen, D. A. A., Vermeir, S. W., Liu, M., Li, W., Chatziandreou, M., Donselaar, T., Du, W., Drulyte, I., Bosch, B.-J., Snijder, J., Turville, S. G., ... Jongkees, S. A. K.

    Proceedings of the National Academy of Sciences of the United States of America, 120(26), Article e2303292120.

  6. Avidity engineering of human heavy-chain-only antibodies mitigates neutralization resistance of SARS-CoV-2 variants

    Du, W., Janssens, R., Mykytyn, A. Z., Li, W., Drabek, D., van Haperen, R., Chatziandreou, M., Rissmann, M., van der Lee, J., van Dortmondt, M., Martin, I. S., van Kuppeveld, F. J. M., Hurdiss, D. L., Haagmans, B. L., Grosveld, F., & Bosch, B.-J.

    Frontiers in Immunology, 14, Article 1111385.

2022

  1. An ACE2-blocking antibody confers broad neutralization and protection against Omicron and other SARS-CoV-2 variants Preprint

    Du, W. J., Hurdiss, D. L., Drabek, D., Mykytyn, A. Z., Kaiser, F. K., Gonzalez-Hernandez, M., Munoz-Santos, D., Lamers, M. M., van Haperen, R., Li, W. T., Drulyte, I., Wang, C. Y., Sola, I., Armando, F., Beythien, G., Ciurkiewicz, M., Baumgartner, W., Guilfoyle, K., Smits, T., ... Bosch, B.

    bioRxiv.

  2. The trispecific DARPin ensovibep inhibits diverse SARS-CoV-2 variants

    Rothenberger, S., Hurdiss, D. L., Walser, M., Malvezzi, F., Mayor, J., Ryter, S., Moreno, H., Liechti, N., Bosshart, A., Iss, C., Calabro, V., Cornelius, A., Hospodarsch, T., Neculcea, A., Looser, T., Schlegel, A., Fontaine, S., Villemagne, D., Paladino, M., ... Trimpert, J.

    Nature Biotechnology, 40(12), 1845-1854.

  3. Antigenic structure of the human coronavirus OC43 spike reveals exposed and occluded neutralizing epitopes

    Wang, C., Hesketh, E. L., Shamorkina, T. M., Li, W., Franken, P. J., Drabek, D., van Haperen, R., Townend, S., van Kuppeveld, F. J. M., Grosveld, F., Ranson, N. A., Snijder, J., de Groot, R. J., Hurdiss, D. L., & Bosch, B.-J.

    Nature Communications, 13(1), 1-15. Article 2921.

  4. An ACE2-blocking antibody confers broad neutralization and protection against Omicron and other SARS-CoV-2 variants of concern

    Du, W., Hurdiss, D. L., Drabek, D., Mykytyn, A. Z., Kaiser, F. K., González-Hernández, M., Muñoz-Santos, D., Lamers, M. M., van Haperen, R., Li, W., Drulyte, I., Wang, C., Sola, I., Armando, F., Beythien, G., Ciurkiewicz, M., Baumgärtner, W., Guilfoyle, K., Smits, T., ... Bosch, B.-J.

    Science immunology, 7(73), 1-15. Article eabp9312.

  5. Fluoxetine targets an allosteric site in the enterovirus 2C AAA+ ATPase and stabilizes a ring-shaped hexameric complex

    Hurdiss, D. L., El Kazzi, P., Bauer, L., Papageorgiou, N., Ferron, F. P., Donselaar, T., Van Vliet, A. L. W., Shamorkina, T. M., Snijder, J., Canard, B., Decroly, E., Brancale, A., Zeev-Ben-Mordehai, T., Förster, F., Van Kuppeveld, F. J. M., & Coutard, B.

    Science advances, 8(1), 1-12. Article abj7615.

2021

  1. Exploring the Effect of Structure-Based Scaffold Hopping on the Inhibition of Coxsackievirus A24v Transduction by Pentavalent N-Acetylneuraminic Acid Conjugates

    Johansson, E., Caraballo, R., Hurdiss, D. L., Mistry, N., Andersson, C. D., Thompson, R. F., Ranson, N. A., Zocher, G., Stehle, T., Arnberg, N., & Elofsson, M.

    International Journal of Molecular Sciences, 22(16), Article 8418.

  2. Structural insights into the cross-neutralization of SARS-CoV and SARS-CoV-2 by the human monoclonal antibody 47D11

    Fedry, J., Hurdiss, D. L., Wang, C., Li, W., Obal, G., Drulyte, I., Du, W., Howes, S. C., van Kuppeveld, F. J. M., Förster, F., & Bosch, B.-J.

    Science advances, 7(23), 1-11. Article eabf5632.

  3. A conserved immunogenic and vulnerable site on the coronavirus spike protein delineated by cross-reactive monoclonal antibodies

    Wang, C., van Haperen, R., Gutiérrez-Álvarez, J., Li, W., Okba, N. M. A., Albulescu, I., Widjaja, I., van Dieren, B., Fernandez-Delgado, R., Sola, I., Hurdiss, D. L., Daramola, O., Grosveld, F., van Kuppeveld, F. J. M., Haagmans, B. L., Enjuanes, L., Drabek, D., & Bosch, B.-J.

    Nature Communications, 12(1), 1-15. Article 1715.

2020

  1. Highly potent anti-SARS-CoV-2 multi-DARPin therapeutic candidates Preprint

    Walser, M., Rothenberger, S., Hurdiss, D. L., Schlegel, A., Calabro, V., Fontaine, S., Villemagne, D., Paladino, M., Hospodarsch, T., Neculcea, A., Cornelius, A., Schildknecht, P., Matzner, M., Haenggi, M., Franchini, M., Kaufmann, Y., Schlegel, I., Iss, C., Loser, T., ... Lewis, S.

    bioRxiv.

  2. Pentavalent Sialic Acid Conjugates Block Coxsackievirus A24 Variant and Human Adenovirus Type 37-Viruses That Cause Highly Contagious Eye Infections

    Johansson, E., Caraballo, R., Mistry, N., Zocher, G., Qian, W., Andersson, C. D., Hurdiss, D. L., Chandra, N., Thompson, R., Frangsmyr, L., Stehle, T., Arnberg, N., & Elofsson, M.

    ACS Chemical Biology, 15(10), 2683–2691.

  3. Dynamics in the murine norovirus capsid revealed by high-resolution cryo-EM

    Snowden, J. S., Chiu, W., Hurdiss, D. L., Adeyemi, O. O., Ranson, N. A., Herod, M. R., & Stonehouse, N. J.

    PLoS Biology, 18(3), Article e3000649.

  4. Rational design of highly potent broad-spectrum enterovirus inhibitors targeting the nonstructural protein 2C

    Bauer, L., Manganaro, R., Zonsics, B., Hurdiss, D. L., Zwaagstra, M., Donselaar, T., Welter, N. G. E., van Kleef, R. G. D. M., Lopez, M. L., Bevilacqua, F., Raman, T., Ferla, S., Bassetto, M., Neyts, J., Strating, J. R. P. M., Westerink, R. H. S., Brancale, A., & van Kuppeveld, F. J. M.

    PLoS Biology, 18(11), Article e3000904.

  5. Cryo-EM structure of coronavirus-HKU1 haemagglutinin esterase reveals architectural changes arising from prolonged circulation in humans

    Hurdiss, D. L., Drulyte, I., Lang, Y., Shamorkina, T. M., Pronker, M. F., van Kuppeveld, F. J. M., Snijder, J., & de Groot, R. J.

    Nature Communications, 11(1), 1-10. Article 4646.

  6. Synthesis and antiviral effect of novel fluoxetine analogues as enterovirus 2C inhibitors

    Manganaro, R., Zonsics, B., Bauer, L., Lorenzo Lopez, M., Donselaar, T., Zwaagstra, M., Saporito, F., Ferla, S., Strating, J. R. P. M., Coutard, B., Hurdiss, D. L., van Kuppeveld, F. J. M., & Brancale, A.

    Antiviral Research, 178, Article 104781.

2019

  1. Identification of the Cell-Surface Protease ADAM9 as an Entry Factor for Encephalomyocarditis Virus

    Baggen, J., Thibaut, H. J., Hurdiss, D. L., Wahedi, M., Marceau, C. D., van Vliet, A. L. W., Carette, J. E., & van Kuppeveld, F. J. M.

    mBio, 10(4), Article e01780-19.

2018

  1. Elucidating the structural basis for differing enzyme inhibitor potency by cryo-EM

    Rawson, S., Bisson, C., Hurdiss, D. L., Fazal, A., McPhillie, M. J., Sedelnikova, S. E., Baker, P. J., Rice, D. W., & Muench, S. P.

    Proceedings of the National Academy of Sciences, 115(8), 1795-1800.

  2. Role of enhanced receptor engagement in the evolution of a pandemic acute hemorrhagic conjunctivitis virus

    Baggen, J., Hurdiss, D. L., Zocher, G., Mistry, N., Roberts, R. W., Slager, J. J., Guo, H., van Vliet, A. L. W., Wahedi, M., Benschop, K., Duizer, E., de Haan, C. A. M., de Vries, E., Casasnovas, J. M., de Groot, R. J., Arnberg, N., Stehle, T., Ranson, N. A., Thibaut, H. J., & van Kuppeveld, F. J. M.

    Proceedings of the National Academy of Sciences of the United States of America, 115(2), 397-402.

2016

  1. New Structural Insights into the Genome and Minor Capsid Proteins of BK Polyomavirus using Cryo-Electron Microscopy

    Hurdiss, D. L., Morgan, E. L., Thompson, R. F., Prescott, E. L., Panou, M. M., Macdonald, A., & Ranson, N. A.

    Structure, 24(4), 528-536.